125 related articles for article (PubMed ID: 2556316)
1. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
[No Abstract] [Full Text] [Related]
2. Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C.
Al-Idrissi HY; Ibrahim EM; Abdel Satir A; Satti MB; Al-Kasem S; Al-Qurain A
Hepatogastroenterology; 1985 Feb; 32(1):8-10. PubMed ID: 2985480
[TBL] [Abstract][Full Text] [Related]
3. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
[No Abstract] [Full Text] [Related]
4. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
Boucher E; Corbinais S; Brissot P; Boudjema K; Raoul JL
Cancer Chemother Pharmacol; 2002 Oct; 50(4):305-8. PubMed ID: 12357305
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
Chauffert B; Seitz JF; Bedenne L; Renard P; Conroy T; Rougier P
Gastroenterol Clin Biol; 1991; 15(10):774-5. PubMed ID: 1667769
[No Abstract] [Full Text] [Related]
7. [Evaluation of chemotherapy in hepatocellular carcinoma with liver cirrhosis].
Munehisa T; Tajima H; Goto M; Nakata K; Muro T; Kawahara K; Kohno K; Sato A; Furukawa R; Ogino T
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2318-23. PubMed ID: 6314913
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of primary and secondary liver cancer: is it useful?
Buzzelli G; Smorlesi C; Mazzanti R; Pampana A; Matassi L; Simondi P; Gentilini P
Chemioterapia; 1986 Jun; 5(3):173-6. PubMed ID: 3013434
[TBL] [Abstract][Full Text] [Related]
9. Systemic cytostatic drug therapy in liver cancer.
Glimelius B
Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
[No Abstract] [Full Text] [Related]
10. Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.
Yau T; Chan P; Pang R; Ng K; Fan ST; Poon RT
Cancer; 2010 Nov; 116(21):5022-9. PubMed ID: 20629034
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: a Southeastern Cancer Study Group trial.
Ravry MJ; Omura GA; Bartolucci AA
Cancer Treat Rep; 1984 Dec; 68(12):1517-8. PubMed ID: 6210143
[No Abstract] [Full Text] [Related]
12. Medical treatment of hepatocellular carcinoma.
Nerenstone S; Friedman M
Gastroenterol Clin North Am; 1987 Dec; 16(4):603-12. PubMed ID: 2831153
[TBL] [Abstract][Full Text] [Related]
13. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987
[TBL] [Abstract][Full Text] [Related]
14. [Intra-arterial chemotherapy using an implantable infusion pump in liver metastases of colorectal tumors and hepatomas].
Balch CM; Urist MM
Chirurg; 1984 Aug; 55(8):485-93. PubMed ID: 6092009
[No Abstract] [Full Text] [Related]
15. [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma].
Zhang ZH; Ma LW; Song SB; Xiu DR; Wang JJ; Yang XX; Jia YM
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):45-7. PubMed ID: 15771799
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary liver cancer: response to regional chemotherapy.
Wellwood JM; Cady B; Oberfield RA
Clin Oncol; 1979 Mar; 5(1):25-31. PubMed ID: 217565
[No Abstract] [Full Text] [Related]
17. Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
Ferrari D; Di Maria G; Fazio N; Codecà C; Fiore J; Luciani A; Oldani S; Maggioni M; Foa P
Anticancer Drugs; 2008 Sep; 19(8):837-40. PubMed ID: 18690097
[TBL] [Abstract][Full Text] [Related]
18. [A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil].
Shitara K; Munakata M; Kudo T; Muto O; Okada R; Mitobe S; Sakata Y; Kondo M; Ishii E; Yabu K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2083-6. PubMed ID: 17197759
[TBL] [Abstract][Full Text] [Related]
19. [A case of successful treatment of advanced hepatocellular carcinoma with tumor thrombi in the major portal branches and inferior vena cava with combined intraarterial 5-fluorouracil, adriamycin and cisplatin therapy].
Ota H; Nagano H; Sakon M; Yamamoto T; Nakamura M; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1673-7. PubMed ID: 14619491
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy for hepatocellular carcinoma].
Okusaka T; Ueno H; Ikeda M
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
